{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:08:38Z","timestamp":1792202918615,"version":"4.4.0"},"reference-count":43,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0378-6323.116738","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T10:06:50Z","timestamp":1376993210000},"page":"686","source":"Crossref","is-referenced-by-count":75,"title":["Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid"],"prefix":"10.25259","volume":"79","author":[{"given":"GK","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.116738-1","first-page":"1272","volume-title":"Severe adverse cutaneous reactions to drugs","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.116738-2","first-page":"269","volume-title":"Treatment strategies in toxic epidermal necrolysis syndrome: Where are we at?","author":"Abood","year":"2008","journal-title":"J Burn Care Res"},{"key":"key-10.4103\/0378-6323.116738-3","first-page":"35","volume-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs.The EuroSCAR-study","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.116738-4","first-page":"1160","volume-title":"Toxic epidermal necrolysis.Clinical findings and prognosis factors in 87 patients","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-5","first-page":"839","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome.An epidemiologic study from West Germany","author":"Sch\u00f6pf","year":"1991","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-6","first-page":"1019","volume-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: Results of an international prospective study","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-7","first-page":"181","volume-title":"Toxic epidermal necrolysis","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.116738-8","first-page":"141","volume-title":"Death receptors in cutaneous biology and disease","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.116738-9","first-page":"272","volume-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","author":"Gu\u00e9gan","year":"2006","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.116738-10","first-page":"149","volume-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.116738-11","first-page":"847","volume-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-12","first-page":"27","volume-title":"Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: Experience with 41 cases and a hypothesis regarding pathogenesis","author":"Patterson","year":"1994","journal-title":"Ann Allergy"},{"key":"key-10.4103\/0378-6323.116738-13","first-page":"218","volume-title":"Plasmapheresis in toxic epidermal necrolysis","author":"Chaidemenos","year":"1997","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-14","first-page":"458","volume-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.116738-15","first-page":"778","volume-title":"Efficacy of cyclophosphamide in toxic epidermal necrolysis.Clinical and pathophysiologic aspects","author":"Heng","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.116738-16","first-page":"1586","volume-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0378-6323.116738-17","first-page":"165","volume-title":"The management of toxic epidermal necrolysis","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-18","first-page":"1122","volume-title":"Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: A retrospective comparative study in China","author":"Yang","year":"2009","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-19","first-page":"452","volume-title":"Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): Experience with high-dose intravenous immunoglobulins and topical conservative approach.A retrospective analysis","author":"Stella","year":"2007","journal-title":"Burns"},{"key":"key-10.4103\/0378-6323.116738-20","first-page":"548","volume-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children","author":"Tristani-Firouzi","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.116738-21","first-page":"430","volume-title":"High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis","author":"Campione","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.116738-22","first-page":"1430","volume-title":"Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: Seven cases and review of the literature","author":"Metry","year":"2003","journal-title":"Pediatrics"},{"key":"key-10.4103\/0378-6323.116738-23","first-page":"26","volume-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-24","first-page":"847","volume-title":"Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis","author":"Al-Mutairi","year":"2004","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-25","first-page":"1","volume-title":"High-dose intravenous immunoglobulins in the treatment of toxic epidermal necrolysis: An Asian series","author":"Tan","year":"2005","journal-title":"J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-26","first-page":"398","volume-title":"Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: An open uncontrolled study","author":"Mangla","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.116738-27","first-page":"33","volume-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-28","first-page":"337","volume-title":"Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin","author":"Zaki","year":"1995","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-29","doi-asserted-by":"crossref","unstructured":"Sullivan JR, Watson A. Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: A discussion of pathogenesis and immunosuppressive management. Australas J Dermatol 1996;37:208-12.","DOI":"10.1111\/j.1440-0960.1996.tb01057.x"},{"key":"key-10.4103\/0378-6323.116738-30","first-page":"146","volume-title":"Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor","author":"Jarrett","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.116738-31","first-page":"473","volume-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","author":"Ar\u00e9valo","year":"2000","journal-title":"J Trauma"},{"key":"key-10.4103\/0378-6323.116738-32","first-page":"31","volume-title":"Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF","author":"Robak","year":"2001","journal-title":"J Med"},{"key":"key-10.4103\/0378-6323.116738-33","first-page":"90","volume-title":"Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate","author":"Hashim","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.116738-34","first-page":"263","volume-title":"Suprapharmacologic doses of intravenous dexamethasone followed by cyclosporine in the treatment of toxic epidermal necrolysis","author":"Rai","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.116738-35","doi-asserted-by":"crossref","unstructured":"Majumdar S, Mockenhaupt M, Roujeau J, Townshend A. Interventions for toxic epidermal necrolysis. Cochrane Database Syst Rev 2002;CD001435.","DOI":"10.1002\/14651858.CD001435"},{"key":"key-10.4103\/0378-6323.116738-36","first-page":"90","volume-title":"Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children","author":"Kakourou","year":"1997","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/0378-6323.116738-37","first-page":"101","volume-title":"Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: A total series of 67 cases","author":"Tripathi","year":"2000","journal-title":"Allergy Asthma Proc"},{"key":"key-10.4103\/0378-6323.116738-38","first-page":"241","volume-title":"Toxic epidermal necrolysis: Current evidence, practical management and future directions","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.116738-39","first-page":"781","volume-title":"Toxic epidermal necrolysis: 15 years\u2032 experience in a Dutch burns centre","author":"Gerdts","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.116738-40","first-page":"33","volume-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.116738-41","first-page":"323","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.116738-42","doi-asserted-by":"crossref","unstructured":"Litt JZ. Litt\u2032s Drug Eruptions and Reference Manual. 16 th ed., London: Informa Healthcare; 2010.","DOI":"10.3109\/9781841848372"},{"key":"key-10.4103\/0378-6323.116738-43","first-page":"24","volume-title":"Cyclosporine for SJS\/TEN: A case series and review of the literature","author":"Reese","year":"2011","journal-title":"Cutis"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:41:21Z","timestamp":1612658481000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/cyclosporine-in-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-and-retrospective-comparison-with-systemic-corticosteroid\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"alternative-id":["116738"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.116738","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}